223 related articles for article (PubMed ID: 16142348)
1. Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study.
Blümke K; Bilkenroth U; Schmidt U; Melchior A; Füssel S; Bartel F; Heynemann H; Fornara P; Taubert H; Wirth MP; Meye A
Oncol Rep; 2005 Oct; 14(4):895-9. PubMed ID: 16142348
[TBL] [Abstract][Full Text] [Related]
2. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP
Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis.
Bluemke K; Bilkenroth U; Meye A; Fuessel S; Lautenschlaeger C; Goebel S; Melchior A; Heynemann H; Fornara P; Taubert H
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2190-4. PubMed ID: 19661076
[TBL] [Abstract][Full Text] [Related]
4. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS.
Martin VM; Siewert C; Scharl A; Harms T; Heinze R; Ohl S; Radbruch A; Miltenyi S; Schmitz J
Exp Hematol; 1998 Mar; 26(3):252-64. PubMed ID: 9502622
[TBL] [Abstract][Full Text] [Related]
5. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
[TBL] [Abstract][Full Text] [Related]
6. Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage.
Kahn HJ; Presta A; Yang LY; Blondal J; Trudeau M; Lickley L; Holloway C; McCready DR; Maclean D; Marks A
Breast Cancer Res Treat; 2004 Aug; 86(3):237-47. PubMed ID: 15567940
[TBL] [Abstract][Full Text] [Related]
7. Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
Thompson RH; Gillett MD; Cheville JC; Lohse CM; Dong H; Webster WS; Chen L; Zincke H; Blute ML; Leibovich BC; Kwon ED
Cancer; 2005 Nov; 104(10):2084-91. PubMed ID: 16208700
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood.
Rosenberg R; Gertler R; Friederichs J; Fuehrer K; Dahm M; Phelps R; Thorban S; Nekarda H; Siewert JR
Cytometry; 2002 Dec; 49(4):150-8. PubMed ID: 12454978
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
Alunni-Fabbroni M; Sandri MT
Methods; 2010 Apr; 50(4):289-97. PubMed ID: 20116432
[TBL] [Abstract][Full Text] [Related]
10. Frequency and prognostic relevance of disseminated tumor cells in bone marrow of patients with metastatic renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Hofstetter A; Stief C; Oberneder R
Cancer; 2006 Apr; 106(7):1514-20. PubMed ID: 16518813
[TBL] [Abstract][Full Text] [Related]
11. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.
Thompson RH; Kuntz SM; Leibovich BC; Dong H; Lohse CM; Webster WS; Sengupta S; Frank I; Parker AS; Zincke H; Blute ML; Sebo TJ; Cheville JC; Kwon ED
Cancer Res; 2006 Apr; 66(7):3381-5. PubMed ID: 16585157
[TBL] [Abstract][Full Text] [Related]
12. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells.
Zheng S; Lin H; Liu JQ; Balic M; Datar R; Cote RJ; Tai YC
J Chromatogr A; 2007 Aug; 1162(2):154-61. PubMed ID: 17561026
[TBL] [Abstract][Full Text] [Related]
13. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
Wechsel HW; Petri E; Bichler KH; Feil G
Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
15. Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer.
Bauernhofer T; Zenahlik S; Hofmann G; Balic M; Resel M; Pirchmoser R; Regitnig P; Ambros P; Dandachi N; Samonigg H
Oncol Rep; 2005 Feb; 13(2):179-84. PubMed ID: 15643496
[TBL] [Abstract][Full Text] [Related]
16. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ
Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568
[TBL] [Abstract][Full Text] [Related]
17. Molecular signature detection of circulating tumor cells using a panel of selected genes.
Gervasoni A; Monasterio Muñoz RM; Wengler GS; Rizzi A; Zaniboni A; Parolini O
Cancer Lett; 2008 May; 263(2):267-79. PubMed ID: 18262345
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
[TBL] [Abstract][Full Text] [Related]
19. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
Sejima T; Miyagawa I
Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
[TBL] [Abstract][Full Text] [Related]
20. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
